It’s clear to me how Dr. Perin would have had a strong influence on the agenda, that being promoting cell therapy as a breakthrough . I just wish that Dr. Rose might eventually fill the last speaking spot, and that it would be just after FDA agreed with the company a pathway for both LVAD and HLHS approval.
It’s clear to me how Dr. Perin would have had a strong influence...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.025(2.22%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.16 | $1.19 | $1.13 | $8.289M | 7.186M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 22569 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.15 | 105374 | 2 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.15 |
Change
0.025 ( 2.46 %) |
||||
| Open | High | Low | Volume | ||
| $1.16 | $1.19 | $1.13 | 1229288 | ||
| Last updated 15.59pm 22/05/2024 ? | |||||
| MSB (ASX) Chart |